Case Report
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2013; 19(31): 5187-5194
Published online Aug 21, 2013. doi: 10.3748/wjg.v19.i31.5187
Figure 5
Figure 5 Overall survival with gonadal choriocarcinoma regimen and adenocarcinoma regimen. The median survival of patients treated with gonadal choriocarcinoma regimens used as the first-line was 9.5 mo compared to 5.0 mo in patients treated with gastric carcinoma regimens. Although this difference was not statistically significant, treatment results showed a favorable prognosis with gonadal choriocarcinoma regimens (P = 0.1).